InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,583.11
(
0.52%
)
US TECH 100
18,866.00
(
0.65%
)
Dow Jones
41,003.60
(
0.35%
)
Brent Oil
71.97
(
2.05%
)
Bitcoin
58,236.80
(
1.56%
)
Post# of 26138
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

jadite

Send PM Follow Ignore
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

jadite

Re: homeslice10 post# 24201

Thursday, 02/21/2013 5:47:09 PM

Thursday, February 21, 2013 5:47:09 PM

Post# of 26138
Mr.Simes

Considering the fact that ANI already sells a testosterone based product for women (Estratest) that is not FDA approved, what specific barriers would the new company encounter if there was a decision to sell non FDA approved Libigel?
If that were to happen how would the partnership with Antares Pharma be affected?


What are the "sales milestones" in the Elestrin deal?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up